VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 183,610 Value ($000) $2,062 Avg Close — Range —
Q1 2025
Shares 133,566 Value ($000) $610 Avg Close — Range —
Q4 2024
Shares 119,818 Value ($000) $676 Avg Close — Range —
Q3 2024
Shares 115,041 Value ($000) $557 Avg Close — Range —
Q2 2024
Shares 108,446 Value ($000) $529 Avg Close — Range —
Q1 2024
Shares 46,592 Value ($000) $619 Avg Close — Range —
Q4 2023
Shares 46,592 Value ($000) $649 Avg Close — Range —
Q3 2023
Shares 46,592 Value ($000) $618 Avg Close — Range —
Q2 2023
Shares 22,515 Value ($000) $325 Avg Close — Range —
Q1 2023
Shares 22,515 Value ($000) $325 Avg Close — Range —
Q4 2022
Shares 21,355 Value ($000) $413 Avg Close — Range —
Q3 2022
Shares 27,502 Value ($000) $944,694 Avg Close — Range —
Q2 2022
Shares 15,000 Value ($000) $229,200 Avg Close — Range —
Q4 2021
Shares 8,100 Value ($000) $298,647 Avg Close — Range —